A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSE(S) OF BNT162B2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162B2
Clinical Trial Grant
Administered By
Duke Human Vaccine Institute
Awarded By
Pfizer, Inc.
Start Date
June 9, 2021
End Date
June 8, 2023
Administered By
Duke Human Vaccine Institute
Awarded By
Pfizer, Inc.
Start Date
June 9, 2021
End Date
June 8, 2023